ALPS Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-124,353
Closed -$425K 1174
2026
Q1
$425K Buy
124,353
+7,981
+7% +$26.9K ﹤0.01% 943
2025
Q4
$329K Sell
116,372
-7,305
-6% -$37.7K ﹤0.01% 931
2025
Q3
$861K Sell
123,677
-15,485
-11% -$109K ﹤0.01% 576
2025
Q2
$824K Buy
139,162
+12,836
+10% +$73.8K ﹤0.01% 559
2025
Q1
$807K Buy
126,326
+2,093
+2% +$20.2K ﹤0.01% 521
2024
Q4
$1.48M Sell
124,233
-36,178
-23% -$617K 0.01% 392
2024
Q3
$4.44M Sell
160,411
-11,389
-7% -$285K 0.03% 244
2024
Q2
$4.1M Buy
+171,800
New +$4.03M 0.03% 246

Other funds holding ASPN

ALPS Advisors's ASPN Position: Q2 2026 in Review

ALPS Advisors sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 124,353 shares — an estimated $425K sold.

ALPS Advisors first reported a position in ASPN in Q2 2024 and held it in 8 quarters. The position peaked at $4.44M in Q3 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • ALPS Advisors reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • ALPS Advisors sold 124,353 Aspen Aerogels shares in Q2 2026, an estimated $425K.
  • ALPS Advisors first reported a position in Aspen Aerogels in Q2 2024 and held it in 8 quarters.
  • ALPS Advisors's Aspen Aerogels position peaked at $4.44M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.